Comprehensive Assessment of Cancer Theranostic Response
Comprehensive Assessment of Cancer Theranostic Response
Active, not recruiting · NCT06815354 · Registry updated 2026-10-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Comprehensive Assessment of Cancer Theranostic Response | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Active, not recruiting | Not applicable | 2026-10-06 | NCT06815354 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AIQ Solutions | 2 |
| M.D. Anderson Cancer Center | 1145 |
| National Cancer Institute (NCI) | 3015 |
| Weill Medical College of Cornell University | 276 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| M.D. Anderson Cancer Center | Houston | United States | 14 |
| Weill Medical College of Cornell | New York | United States | 1 |